Yi Zheng

Statistics

Publications

Citations

329

H-Index

Active since

2012

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

First Hospital of Shijiazhuang

University of Chinese Academy of Sciences

Affiliated Hospital of Chengde Medical College

Chinese University of Hong Kong, Shenzhen

Yi Zheng is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

2012–2023

Publications

Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer

Han Li, You Yu, Yi Liu et al. · Pharmacological Research · 2022 · 89 citations

Medicine, Oncology, Pharmacology +11

A red emission fluorescent probe for hydrogen sulfide and its application in living cells imaging

Tao Chen, Yi Zheng, Zhaochao Xu et al. · Tetrahedron Letters · 2013 · 48 citations

Natural Sciences, Biophysics, Cell Biology +16

Multifunctional biodegradable nanoplatform based on oxaliplatin prodrug cross-linked mesoporous polydopamine for enhancing cancer synergetic therapy

Ping Sun, Zimu Li, Dan Zhang et al. · Chinese Chemical Letters · 2023 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +16

ZEB1-activated LINC01123 accelerates the malignancy in lung adenocarcinoma through NOTCH signaling pathway

Miao Zhang, Yaguang Han, Yi Zheng et al. · Cell Death and Disease · 2020 · 37 citations · Full text

Medicine, Molecular Biology, Oncology +17

PTEN and PDCD4 are bona fide targets of microRNA-21 in human cholangiocarcinoma.

Changzheng Liu, Wei Liu, Yi Zheng et al. · PubMed · 2012 · 32 citations

Medicine, Molecular Biology, Oncology +17

1–5 of 9